FRANKFURT, March 5 (Reuters) - Bayer said on

Tuesday that it does not plan to change the group's diversified

structure in the near future and will instead focus on improving

the operating performance of the maker of drugs and farming

products.

"Our answer is 'not now' - and this shouldn't be

misunderstood as 'never'," CEO Bill Anderson said in a

statement.

"Of course, we will keep an open mind," he added.